PFIZERPEN
Details
- Status
- Prescription
- First Approved
- 1968-08-30
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
PFIZERPEN Approval History
What PFIZERPEN Treats
10 indicationsPFIZERPEN is approved for 10 conditions since its original approval in 1968. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Septicemia
- Empyema
- Pneumonia
- Pericarditis
- Endocarditis
- Meningitis
- Anthrax
- Actinomycosis
Drugs Similar to PFIZERPEN
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
PFIZERPEN FDA Label Details
ProIndications & Usage
Therapy Penicillin G Potassium for Injection is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to penicillin G. Therapy with Penicillin G Potassium for Injection may be initiated before results of such tests are known when there is reason to believe the infection may involve any of the organisms listed below; however, once th...
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.